source
- Cytospire secures $83 million to develop pan-gamma delta T-cell engagersCytospire, a British biotechnology startup, announced it raised £61 million, about $83 million, to fund the development of a new type of T-cell engager therapy. The company is targeting a "pan-gam…
- Parsley Health joins nationwide insurance networks, expanding access to its primary-care modelParsley Health, a decade-old primary-care startup that originally operated on a cash-pay model, announced that it is now in-network with insurers across the United States. The move marks a shift f…